Breakthrough cases are U.S. residents with a SARS-CoV-2 RNA or antigen detected on respiratory specimen collected ≥14 days after completing the primary series of an FDA-authorized COVID-19 vaccine (i.e., complete vaccination).

COVID-19 Dashboard
Maps, Reports and Trends
Weekly City Reports